Ultragenyx Pharmaceutical RARE Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's free cash flow margin?
- Ultragenyx Pharmaceutical (RARE) reported free cash flow margin of -75.1% in Q1 2026.
- How has Ultragenyx Pharmaceutical's free cash flow margin changed year-over-year?
- Ultragenyx Pharmaceutical's free cash flow margin decreased by 12.5% year-over-year, from -66.8% to -75.1%.
- What is the long-term trend for Ultragenyx Pharmaceutical's free cash flow margin?
- Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's free cash flow margin has grown at a -12.0% compound annual growth rate (CAGR), from -117.2% to -70.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.